3–8 Sept 2017
The Open University, Milton Keynes, UK.
Europe/London timezone

Session

Applications in life sciences, biology and medicine: Protons

6 Sept 2017, 11:00

Presentation materials

There are no materials yet.

  1. Michela Esposito (University of Lincoln)
    06/09/2017, 11:00
    Talk

    The use of Proton Therapy for cancer treatment demands new and more accurate imaging modalities for treatment planning, based on direct measurements of tissue stopping power instead of tissue density (as in conventional X-ray Computed Tomography) to reduce the errors in converting the latter quantity into the former [1]. The expected benefits of proton CT (pCT) for treatment planning in Proton...

    Go to contribution page
  2. Anna Vignati (INFN - National Institute for Nuclear Physics - Torino (IT))
    06/09/2017, 11:20
    Talk

    Purpose. A multidisciplinary project (Move-IT) of the Italian National Institute for Nuclear Physics (INFN) aims at translating research in charged particle therapy into clinical outcome. To this scope, new models in the treatment planning system will be developed and validated, using dedicated devices for beam characterization and monitoring in radiobiological and clinical irradiations....

    Go to contribution page
  3. Jon Taylor (University of Liverpool (GB))
    06/09/2017, 11:40
    Talk

    Tomography has found extensive applications in medicine, industry and security due to its ability to produce detailed 3D images of objects and their internal structure. In medicine, computed tomography (CT) using x-rays is routinely used for the treatment planning of radiotherapy which most often uses x-rays for treating patients with various types of cancer. Radiotherapy using beams of...

    Go to contribution page
  4. Dr Benjamin Le Crom (University of Liverpool)
    06/09/2017, 12:00
    Talk

    The demand for proton therapy as a form of cancer treatment has been growing rapidly over the past decade. This is due to the sharp Bragg peak of the protons, which potentially enables radiation dose to be closely conformed to tumour dimensions, hence sparing normal tissues.

    However, uncertainties in the proton range in tissue, beam delivery and resulting dose deposition in the patient,...

    Go to contribution page
Building timetable...